Movement Alert｜Charles River Laboratories Intraday Rise 5.68% in Regular Trading, Jefferies Raises Price Target to $385

Market Focus

Yesterday

On November 6, Charles River Laboratories rose 5.68% in Regular Trading, trading at $330.64/share, with turnover of $21.03 million.

The clearest catalyst was a fresh analyst action: Jefferies raised its price target on Charles River Laboratories to $385 from $340, above the FactSet-tracked average target of $358.07, reinforcing attention on potential valuation re-rating.

The backdrop is the company’s latest quarterly report released on November 4. Charles River Laboratories posted adjusted EPS of $3.09, above the $2.97 market expectation, and revenue of $982.7 million, ahead of the $960.4 million consensus. The company also lifted its full-year non-GAAP EPS guidance to $11.35-$11.55 and narrowed its expected full-year revenue decline to 2% to 1.5%, indicating improving profit recovery even as revenue remains below the prior-year level.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www-web.itiger.com/news/1181109118"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1181109118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1181109118?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-11-06 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181109118","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Charles River Laboratories Intraday Rise 5.68% in Regular Trading, Jefferies Raises Price Target to $385","media":"Market Focus","content":"<p><p>On November 6, Charles River Laboratories rose 5.68% in Regular Trading, trading at $330.64/share, with turnover of $21.03 million.</p><p>The clearest catalyst was a fresh analyst action: Jefferies raised its price target on Charles River Laboratories to $385 from $340, above the FactSet-tracked average target of $358.07, reinforcing attention on potential valuation re-rating.</p><p>The backdrop is the company’s latest quarterly report released on November 4. Charles River Laboratories posted adjusted EPS of $3.09, above the $2.97 market expectation, and revenue of $982.7 million, ahead of the $960.4 million consensus. The company also lifted its full-year non-GAAP EPS guidance to $11.35-$11.55 and narrowed its expected full-year revenue decline to 2% to 1.5%, indicating improving profit recovery even as revenue remains below the prior-year level.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Charles River Laboratories Intraday Rise 5.68% in Regular Trading, Jefferies Raises Price Target to $385</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Charles River Laboratories Intraday Rise 5.68% in Regular Trading, Jefferies Raises Price Target to $385\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-11-06 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On November 6, Charles River Laboratories rose 5.68% in Regular Trading, trading at $330.64/share, with turnover of $21.03 million.</p><p>The clearest catalyst was a fresh analyst action: Jefferies raised its price target on Charles River Laboratories to $385 from $340, above the FactSet-tracked average target of $358.07, reinforcing attention on potential valuation re-rating.</p><p>The backdrop is the company’s latest quarterly report released on November 4. Charles River Laboratories posted adjusted EPS of $3.09, above the $2.97 market expectation, and revenue of $982.7 million, ahead of the $960.4 million consensus. The company also lifted its full-year non-GAAP EPS guidance to $11.35-$11.55 and narrowed its expected full-year revenue decline to 2% to 1.5%, indicating improving profit recovery even as revenue remains below the prior-year level.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRL","symbol_name":"查尔斯河","start_time":0,"source_url":"","article_id":"1181109118","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181109118","pubTimestamp":1793976879,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On November 6, Charles River Laboratories rose 5.68% in Regular Trading, trading at $330.64/share, with turnover of $21.03 million.The clearest catalyst was a fresh analyst action: Jefferies raised...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRL":"查尔斯河"},"translate_title":"走势警报|查尔斯河实验室常规交易盘中上涨 5.68%，杰富瑞将目标价上调至 385 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":1},"content_text":"On November 6, Charles River Laboratories rose 5.68% in Regular Trading, trading at $330.64/share, with turnover of $21.03 million.The clearest catalyst was a fresh analyst action: Jefferies raised its price target on Charles River Laboratories to $385 from $340, above the FactSet-tracked average target of $358.07, reinforcing attention on potential valuation re-rating.The backdrop is the company’s latest quarterly report released on November 4. Charles River Laboratories posted adjusted EPS of $3.09, above the $2.97 market expectation, and revenue of $982.7 million, ahead of the $960.4 million consensus. The company also lifted its full-year non-GAAP EPS guidance to $11.35-$11.55 and narrowed its expected full-year revenue decline to 2% to 1.5%, indicating improving profit recovery even as revenue remains below the prior-year level.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}